title: Elevated hepatocyte growth factor level correlates with poor outcome in early-stage and late-stage adenocarcinoma of the lung.
authors.affiliation: Department of Pharmacology, University of Pittsburgh Cancer Institute, Pittsburgh, PA 15213-1863, USA. siegfriedjm@upmc.edu
authors.forename: Jill M
authors.initials: JM
authors.lastname: Siegfried
authors.forename: James D
authors.initials: JD
authors.lastname: Luketich
authors.forename: Laura P
authors.initials: LP
authors.lastname: Stabile
authors.forename: Neil
authors.initials: N
authors.lastname: Christie
authors.forename: Stephanie R
authors.initials: SR
authors.lastname: Land
mesh_terms: D000230:Adenocarcinoma / Q000737:chemistry* / Q000401:mortality / Q000473:pathology; D017228:Hepatocyte Growth Factor / Q000032:analysis*; D006801:Humans; D008175:Lung Neoplasms / Q000737:chemistry* / Q000401:mortality / Q000473:pathology; D015999:Multivariate Analysis; D009367:Neoplasm Staging; D011379:Prognosis; D016019:Survival Analysis; D015996:Survival Rate
chemical_list: D017228:Hepatocyte Growth Factor